Difference between revisions of "Serpentis Inquest"
From EVE University Wiki
(Recategorized.) |
(marked for deletion) |
||
| Line 1: | Line 1: | ||
| − | The '''Serpentis Inquest''' is a offspring of the [[Serpentis Corporation]] that is also a research company, but instead of focusing on neural boosters Inquest is researching black cyber implants and alternative cloning methods. | + | {{deletion|No reason to have}}The '''Serpentis Inquest''' is a offspring of the [[Serpentis Corporation]] that is also a research company, but instead of focusing on neural boosters Inquest is researching black cyber implants and alternative cloning methods. |
==Attributes== | ==Attributes== | ||
Revision as of 16:04, 27 January 2018
This article is a candidate for deletion.
Reason: No reason to have
Reason: No reason to have
The Serpentis Inquest is a offspring of the Serpentis Corporation that is also a research company, but instead of focusing on neural boosters Inquest is researching black cyber implants and alternative cloning methods.
Attributes
- Ticker: SPI
- Headquarters: Serpentis Prime VI - Moon 1 - Serpentis Inquest Biotech Research Center
- Offices: 1 in 1 systems
- Shares: 332427989
- Share price: 81
- Activity: Biotech
- Partner: Eifyr and Co.
- Competitor: Zero-G Research Firm
CEO
Otuwiri Huohalen
Divisions
Administration
- CFO: Achi Astenaisen
Intelligence
- Chief Operative: Onlar Skadidsar
Production
- Production Manager: Engardin Trahad
Personnel
- Chief of Staff: Ersi Argrik
